Equities

Animalcare Group plc

ANCR:LSE

Animalcare Group plc

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)280.00
  • Today's Change-8.00 / -2.78%
  • Shares traded54.65k
  • 1 Year change18.64%
  • Beta0.8284
Data delayed at least 20 minutes, as of Feb 06 2026 09:57 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Animalcare Group plc grew net income 1,442.45% from 1.20m to 18.49m primarily through revenue growth (70.73m to 74.23m). For while the costs associated with cost of goods, selling, general and administrative and debt all increased as a percentage of sales, the 4.94% growth in revenues contributed enough to still see net income improve.
Gross margin56.36%
Net profit margin3.68%
Operating margin4.39%
Return on assets2.08%
Return on equity2.83%
Return on investment2.42%
More ▼

Cash flow in GBPView more

In 2024, Animalcare Group plc increased its cash reserves by 152.37%, or 7.07m. Cash Flow from Financing totalled 32.12m or 43.27% of revenues. In addition the company generated 11.35m in cash from operations while cash used for investing totalled 33.86m.
Cash flow per share0.1699
Price/Cash flow per share17.84
Book value per share1.64
Tangible book value per share-0.0201
More ▼

Balance sheet in GBPView more

Animalcare Group plc has a Debt to Total Capital ratio of 15.66%, a higher figure than the previous year's 3.53%.
Current ratio1.93
Quick ratio1.27
Total debt/total equity0.1856
Total debt/total capital0.1566
More ▼

Growth rates in GBP

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items increased 339.02%. Additionally, five year annualized dividend per share growth ranks highest in its industry.
Div yield(5 year avg)1.92%
Div growth rate (5 year)20.11%
Payout ratio (TTM)60.48%
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		-43.13
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.